Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - piracetam - solution - 20% w/v - piracetam 20g/100ml

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - piracetam - tablet, film coated - 800 mg - piracetam 800.00 mg

Malta - English - Medicines Authority

janssen-cilag international nv turnhoutsewes 30, b-2340 beerse, belgium - haloperidol - tablet - haloperidol 5 mg - psycholeptics

Malta - English - Medicines Authority

ucb pharma sa 60 allee de la recherche, b-1070 brussels, belgium - piracetam - film-coated tablet - piracetam 800 mg - psychoanaleptics

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - carbidopa, levodopa - tablet prolonged release - 50/200 milligram - dopa and dopa derivatives

Australia - English - Department of Health (Therapeutic Goods Administration)

amplitude australia pty ltd - 32848 - reamer,orthopaedic,acetabular - an orthopaedic surgical instrument kit used to cut and accurately resurface the acetabulum for the acceptance of the acetabular component of a hip joint replacement. kit includes reamers with straight and offset reamer handles.

Canada - English - Health Canada

h & s chemicals, division of huntington labs inc. - benzalkonium chloride; alkyl dimethyl ethylbenzyl ammonium chloride - liquid - .09%; .09% - benzalkonium chloride .09%; alkyl dimethyl ethylbenzyl ammonium chloride .09% - disinfectants (for agents used on object)

Canada - English - Health Canada

h & s chemicals, division of huntington labs inc. - alkyl dimethyl ethylbenzyl ammonium chloride; benzalkonium chloride - aerosol - .09%; .09% - alkyl dimethyl ethylbenzyl ammonium chloride .09%; benzalkonium chloride .09% - disinfectants (for agents used on object)

Canada - English - Health Canada

h & s chemicals, division of huntington labs inc. - benzalkonium chloride - liquid - 10% - benzalkonium chloride 10% - disinfectants (for agents used on object)

United States - English - NLM (National Library of Medicine)

neurocrine biosciences, inc. - valbenazine tosylate (unii: 5sml1t733b) (valbenazine - unii:54k37p50kh) - valbenazine 40 mg - ingrezza is indicated for the treatment of adults with: - tardive dyskinesia [see clinical studies ( 14.1 )] . - chorea associated with huntington’s disease [see clinical studies ( 14.2 )] . ingrezza is contraindicated in patients with a history of hypersensitivity to valbenazine or any components of ingrezza. rash, urticaria, and reactions consistent with angioedema (e.g., swelling of the face, lips, and mouth) have been reported [see warnings and precautions ( 5.2 ) and adverse reactions ( 6.2 )]. risk summary the limited available data on ingrezza use in pregnant women are insufficient to inform a drug-associated risk. in animal reproductive studies, no malformations were observed when valbenazine was administered orally to rats and rabbits during the period of organogenesis at doses up to 1.8 or 24 times, respectively, the maximum recommended human dose (mrhd) of 80 mg/day based on mg/m2 body surface area. however, administration of valbenazine to pregnant rats during organogenesis through lactation p